GALEAS Bladder
Urine targeted NGS biomarker test used as a molecular triage and diagnostic aid for bladder cancer.
- Developer
- Nonacus
- Intended use
- Diagnostic Aid
- Cancer scope
- Urothelial cancer
- Specimen
- Urine
- Molecular modality
- DNA mutation
- Current version
- Current GALEAS Bladder configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.